These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28397431)

  • 1. The effects and safety of intravitreal triamcinolone injections in the treatment of diabetic macular edema.
    Zając-Pytrus HM; Kaczmarek R; Strońska-Lipowicz D; Pomorska M; Misiuk-Hojło M
    Adv Clin Exp Med; 2017; 26(1):45-49. PubMed ID: 28397431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of early injection of intravitreal triamcinolone acetonide (IVTA) versus delayed injection for macular edema resulting from retinal vein occlusion].
    Saleh M; Gaucher D; Letsch J; Bourcier T; Speeg-Schatz C
    J Fr Ophtalmol; 2011 Jun; 34(6):355-61. PubMed ID: 21652108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
    Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S
    Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation.
    Cakir M; Dogan M; Bayraktar Z; Bayraktar S; Acar N; Altan T; Kapran Z; Yilmaz OF
    Retina; 2008 Mar; 28(3):465-72. PubMed ID: 18327140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review.
    Yilmaz T; Weaver CD; Gallagher MJ; Cordero-Coma M; Cervantes-Castaneda RA; Klisovic D; Lavaque AJ; Larson RJ
    Ophthalmology; 2009 May; 116(5):902-11; quiz 912-3. PubMed ID: 19410949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of photocoagulation with combined intravitreal triamcinolone for diabetic macular edema.
    Lee HY; Lee SY; Park JS
    Korean J Ophthalmol; 2009 Sep; 23(3):153-8. PubMed ID: 19794940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal bevacizumab vs intravitreal triamcinolone combined with macular laser grid for diffuse diabetic macular oedema.
    Forte R; Cennamo GL; Finelli M; Farese E; D'Amico G; Nicoletti G; de Crecchio G; Cennamo G
    Eye (Lond); 2010 Aug; 24(8):1325-30. PubMed ID: 20300127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ISIS-DME: a prospective, randomized, dose-escalation intravitreal steroid injection study for refractory diabetic macular edema.
    Kim JE; Pollack JS; Miller DG; Mittra RA; Spaide RF;
    Retina; 2008 May; 28(5):735-40. PubMed ID: 18463518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of postvitrectomy intravitreal triamcinolone therapy for diabetic macular edema.
    Costa JF; Sousa K; Marques JP; Marques M; Cachulo ML; Silva R; Gomes N; Figueira J
    Eur J Ophthalmol; 2016 Aug; 26(5):485-90. PubMed ID: 26951531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of diabetic macular edema with intravitreal triamcinolone acetonide injection: functional and anatomical outcomes].
    Selim Kocabora M; Kucuksahin H; Gulkilik G; Taskapili M; Yilmazli C; Engin G
    J Fr Ophtalmol; 2007 Jan; 30(1):32-8. PubMed ID: 17287669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal triamcinolone versus laser photocoagulation as a primary treatment for diabetic macular oedema--a comparative pilot study.
    Norlaili M; Bakiah S; Zunaina E
    BMC Ophthalmol; 2011 Nov; 11():36. PubMed ID: 22111945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deferred intravitreal triamcinolone in diabetic eyes after phacoemulsification.
    Campos A; Beselga D; Mendes S; Campos J; Neves A; Sousa P
    J Ocul Pharmacol Ther; 2014 Nov; 30(9):717-28. PubMed ID: 25111757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the short-term effects of intravitreal triamcinolone acetonide and bevacizumab injection for diabetic macular edema.
    Song JH; Lee JJ; Lee SJ
    Korean J Ophthalmol; 2011 Jun; 25(3):156-60. PubMed ID: 21655039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema.
    Ozdek S; Bahçeci UA; Gürelik G; Hasanreisoğlu B
    J Diabetes Complications; 2006; 20(4):246-51. PubMed ID: 16798476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal steroids for macular edema in diabetes.
    Grover D; Li TJ; Chong CC
    Cochrane Database Syst Rev; 2008 Jan; (1):CD005656. PubMed ID: 18254088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema and Macular Edema Secondary to Retinal Vein Occlusion: A Meta-Analysis.
    Mihalache A; Hatamnejad A; Patil NS; Popovic MM; Kertes PJ; Cruz-Pimentel M; Muni RH
    Ophthalmologica; 2024; 247(1):19-29. PubMed ID: 37579730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of intravitreal triamcinolone acetonide versus intravitreal bevacizumab as the primary treatment of clinically significant macular edema.
    Liu Q; Hu Y; Yu H; Yuan L; Hu J; Atik A; Guan M; Li D; Li X; Tang S
    Retina; 2015 Feb; 35(2):272-9. PubMed ID: 25105313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the Efficacy of Sub-Tenon versus Intravitreal Triamcinolone Acetonide Injection during Cataract Surgery for Diabetic Macular Edema.
    Tatsumi T; Oshitari T; Ando T; Takatsuna Y; Arai M; Baba T; Sato E; Yamamoto S
    Ophthalmologica; 2019; 241(1):17-23. PubMed ID: 30041252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal triamcinolone for diabetic macular edema: comparison of 1, 2, and 4 mg.
    Hauser D; Bukelman A; Pokroy R; Katz H; Len A; Thein R; Parness-Yossifon R; Pollack A
    Retina; 2008 Jun; 28(6):825-30. PubMed ID: 18536598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-year results of a randomized trial with open-label extension of triamcinolone acetonide for refractory diabetic macular edema.
    Gillies MC; Simpson JM; Gaston C; Hunt G; Ali H; Zhu M; Sutter F
    Ophthalmology; 2009 Nov; 116(11):2182-7. PubMed ID: 19796823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.